Nexgel Ownership
| NXGL Stock | USD 2.84 0.04 1.39% |
Shares in Circulation | First Issued 2017-12-31 | Previous Quarter 6.3 M | Current Value 6.6 M | Avarage Shares Outstanding 5.6 M | Quarterly Volatility 270.3 K |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Nexgel |
Nexgel Stock Ownership Analysis
About 21.0% of the company outstanding shares are owned by corporate insiders. The book value of Nexgel was now reported as 0.69. The company recorded a loss per share of 0.59. Nexgel Inc had not issued any dividends in recent years. The entity had 3:2 split on the 2nd of August 1990. NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania. Nexgel operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 10 people. To find out more about Nexgel Inc contact Adam Levy at 215 702 8550 or learn more at https://nexgel.com.Besides selling stocks to institutional investors, Nexgel also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Nexgel's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Nexgel's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Nexgel Quarterly Liabilities And Stockholders Equity |
|
Nexgel Insider Trades History
About 21.0% of Nexgel Inc are currently held by insiders. Unlike Nexgel's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Nexgel's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Nexgel's insider trades
Nexgel Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Nexgel is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nexgel Inc backward and forwards among themselves. Nexgel's institutional investor refers to the entity that pools money to purchase Nexgel's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Sbi Securities Co Ltd | 2024-12-31 | 607 | Advisor Group Holdings, Inc. | 2024-12-31 | 310 | Bank Of America Corp | 2024-12-31 | 44.0 | Jpmorgan Chase & Co | 2024-12-31 | 12.0 | Susquehanna International Group, Llp | 2024-09-30 | 0.0 | Ubs Group Ag | 2024-12-31 | 0.0 | Renaissance Technologies Corp | 2024-12-31 | 158.3 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 87.8 K | Geode Capital Management, Llc | 2024-12-31 | 60.1 K | Vanguard Group Inc | 2024-12-31 | 50 K | Massey, Quick & Co. Llc | 2024-12-31 | 35.7 K |
Nexgel Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nexgel insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nexgel's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nexgel insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Nexgel Outstanding Bonds
Nexgel issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Nexgel Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Nexgel bonds can be classified according to their maturity, which is the date when Nexgel Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| NextEra Energy Operating Corp BondUS65342QAB86 | View | |
| NextEra Energy Operating Corp BondUS65342QAL68 | View | |
| Nexstar Escrow 5625 Corp BondUS65343HAA95 | View | |
| US65342VAA98 Corp BondUS65342VAA98 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Nexgel Corporate Filings
F4 | 11th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 22nd of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 13th of November 2024 Other Reports | ViewVerify | |
10Q | 19th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Revenue Per Share | Quarterly Revenue Growth 1.408 | Return On Assets | Return On Equity |
The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.